SLI
|
1 994,13
|
6,21
|
0,31 %
|
Analysen zu SLI-Werten
| 26.01.24 | Givaudan Sell | UBS AG | |
| 26.01.24 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 25.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 25.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 25.01.24 | Givaudan Sell | UBS AG | |
| 24.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 24.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 22.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 22.01.24 | Richemont Buy | Deutsche Bank AG | |
| 22.01.24 | Roche Hold | Deutsche Bank AG | |
| 19.01.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 19.01.24 | Richemont Overweight | Barclays Capital | |
| 19.01.24 | ABB Sector Perform | RBC Capital Markets | |
| 19.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 19.01.24 | Richemont Buy | Deutsche Bank AG | |
| 19.01.24 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.01.24 | Richemont Buy | UBS AG | |
| 19.01.24 | UBS Underweight | Barclays Capital | |
| 19.01.24 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.24 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 18.01.24 | ams-OSRAM buy | Deutsche Bank AG | |
| 18.01.24 | Richemont Outperform | Bernstein Research | |
| 18.01.24 | ams-OSRAM Buy | Deutsche Bank AG | |
| 18.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 18.01.24 | Richemont Buy | UBS AG | |
| 18.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 17.01.24 | Swiss Re Sell | UBS AG | |
| 17.01.24 | Zurich Insurance Neutral | UBS AG | |
| 16.01.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 16.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 16.01.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 15.01.24 | Roche Neutral | UBS AG | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 15.01.24 | UBS Kaufen | DZ BANK |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.